Hence, we aim to review and summarize the current status of FGF21 research in critical illness, including acute lung injury (ALI), acute respiratory distress syndrome (ARDS), acute myocardial injury (AMI), acute kidney injury (AKI), sepsis, and liver failure. This evidence concerns the gene FGF21 and Sepsis.